BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin Z, Lu Y, Wu X, Pan T, Yu Z, Hou J, Wu A, Li J, Yang Z, Li C, Yan M, Yan C, Zhu Z, Liu B, Qiu W, Su L. The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer. Redox Biol 2021;46:102076. [PMID: 34315112 DOI: 10.1016/j.redox.2021.102076] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Byun JK. Tumor lactic acid: a potential target for cancer therapy. Arch Pharm Res 2023. [PMID: 36729274 DOI: 10.1007/s12272-023-01431-8] [Reference Citation Analysis]
2 Tao Z, Huang C, Wang D, Wang Q, Gao Q, Zhang H, Zhao Y, Wang M, Xu J, Shen B, Zhou C, Zhu W. Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation. Exp Cell Res 2023;424:113492. [PMID: 36702194 DOI: 10.1016/j.yexcr.2023.113492] [Reference Citation Analysis]
3 Zhu Y, Wang X, Chen Z, Zhou L, Di X, Fan P, He Z. Anlotinib Suppressed Ovarian Cancer Progression via Inducing G2/M Phase Arrest and Apoptosis. J Clin Med 2022;12. [PMID: 36614964 DOI: 10.3390/jcm12010162] [Reference Citation Analysis]
4 Ji Y, Li X, Qi Y, Zhao J, Zhang W, Qu P. Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo. Molecules 2022;27. [PMID: 36558006 DOI: 10.3390/molecules27248873] [Reference Citation Analysis]
5 Ma R, Li X, Gong S, Ge X, Zhu T, Ge X, Weng L, Tao Q, Guo J. Dual Roles of Lactate in EGFR-TKI-Resistant Lung Cancer by Targeting GPR81 and MCT1. J Oncol 2022;2022:3425841. [PMID: 36545125 DOI: 10.1155/2022/3425841] [Reference Citation Analysis]
6 Zhou Y, Bao T, Xie J, Yao L, Yu S, Huang P, Li Q, Chen S, Zhou W, Wang X, Zhang X, Jiang S, Yi S, Zhang Z, Ma M, Hu L, Li J, Xu J. The SLITRK4-CNPY3 axis promotes liver metastasis of gastric cancer by enhancing the endocytosis and recycling of TrkB in tumour cells.. [DOI: 10.21203/rs.3.rs-2329872/v1] [Reference Citation Analysis]
7 Fang Z, Meng Q, Xu J, Wang W, Zhang B, Liu J, Liang C, Hua J, Zhao Y, Yu X, Shi S. Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives. Cancer Commun (Lond) 2023;43:3-41. [PMID: 36424360 DOI: 10.1002/cac2.12392] [Reference Citation Analysis]
8 Yang L, Qiao P, Zhang J, Chen X, Hu A, Huang S. Crosstalk between ROCK1 and PYROXD1 regulates CAFs activation and promotes laryngeal squamous cell carcinoma metastasis. Discov Onc 2022;13:120. [DOI: 10.1007/s12672-022-00578-y] [Reference Citation Analysis]
9 Lu Y, Jin Z, Hou J, Wu X, Yu Z, Yao L, Pan T, Chang X, Yu B, Li J, Li C, Yan M, Yan C, Zhu Z, Liu B, Su L. Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer. Matrix Biology 2022. [DOI: 10.1016/j.matbio.2022.11.005] [Reference Citation Analysis]
10 Iyer KK, van Erp NP, Tauriello DV, Verheul HM, Poel D. Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer. Cancer Treatment Reviews 2022;110:102466. [DOI: 10.1016/j.ctrv.2022.102466] [Reference Citation Analysis]
11 Sun H, Wang X, Wang X, Xu M, Sheng W. The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer. Cell Death Dis 2022;13:874. [PMID: 36244987 DOI: 10.1038/s41419-022-05320-8] [Reference Citation Analysis]
12 Li J, Qiao H, Wu F, Sun S, Feng C, Li C, Yan W, Lv W, Wu H, Liu M, Chen X, Liu X, Wang W, Cai Y, Zhang Y, Zhou Z, Zhang Y, Zhang S. A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses. Front Immunol 2022;13:998140. [DOI: 10.3389/fimmu.2022.998140] [Reference Citation Analysis]
13 Li J, Zhang Y, Li C, Wu H, Feng C, Wang W, Liu X, Zhang Y, Cai Y, Jia Y, Qiao H, Wu F, Zhang S. A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer. Front Genet 2022;13:956246. [DOI: 10.3389/fgene.2022.956246] [Reference Citation Analysis]
14 Sang Q, Dai W, Yu J, Chen Y, Fan Z, Liu J, Li F, Li J, Wu X, Hou J, Yu B, Feng H, Zhu Z, Su L, Li Y, Liu B. Identification of prognostic gene expression signatures based on the tumor microenvironment characterization of gastric cancer. Front Immunol 2022;13:983632. [DOI: 10.3389/fimmu.2022.983632] [Reference Citation Analysis]
15 Simón L, Sanhueza S, Gaete-Ramírez B, Varas-Godoy M, Quest AFG. Role of the Pro-Inflammatory Tumor Microenvironment in Extracellular Vesicle-Mediated Transfer of Therapy Resistance. Front Oncol 2022;12:897205. [PMID: 35646668 DOI: 10.3389/fonc.2022.897205] [Reference Citation Analysis]
16 Niu D, Wu Y, Lei Z, Zhang M, Xie Z, Tang S. Lactic acid, a driver of tumor-stroma interactions. International Immunopharmacology 2022;106:108597. [DOI: 10.1016/j.intimp.2022.108597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chen X, Zhao Y, Zhang C, Wang X, Zhang X, Chen X, Yuan C, Zhao Q, Chen X. Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma: A Retrospective, Real-World Study in China. DDDT 2022;Volume 16:1483-1493. [DOI: 10.2147/dddt.s358092] [Reference Citation Analysis]
18 Hu D, Li Z, Zheng B, Lin X, Pan Y, Gong P, Zhuo W, Hu Y, Chen C, Chen L, Zhou J, Wang L. Cancer-associated fibroblasts in breast cancer: Challenges and opportunities. Cancer Commun (Lond) 2022. [PMID: 35481621 DOI: 10.1002/cac2.12291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chen C, Guo Y, Huang Q, wang B, Wang W, Niu J, Lou J, Xu J, Ren T, Huang Y, Guo W. PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Sun L, Chen S, Chen M. Schwann Cells in the Tumor Microenvironment: Need More Attention. J Oncol 2022;2022:1058667. [PMID: 35186076 DOI: 10.1155/2022/1058667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Li Y, Mo H, Wu S, Liu X, Tu K. A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:801959. [PMID: 35047511 DOI: 10.3389/fcell.2021.801959] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
22 Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat 2021;:100797. [PMID: 34955385 DOI: 10.1016/j.drup.2021.100797] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]